PALIPalisade Bio, Inc.
2.100USD-2.78%Mkt Cap: 365.97M $P/E: 3.233d ago
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its l…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap365.97M $
Enterprise Value233.83M $
Revenue (TTM)500.00K $
Gross Profit500.00K $
Net Income (TTM)-16.78M $
Revenue/Share0.0030 USD
Last Price2.100 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6963892046
Valuation
P/E (Trailing)3.23
P/E (Forward)-7.36
PEG—
EV/EBITDA-6.62
EV/Revenue467.65
P/S717.99
P/B2.94
EPS (TTM)0.62
EPS (Forward)-0.28
52W Range
0.530067% of range2.860
52W High2.860 USD
52W Low0.5300 USD
Profitability
Gross Margin100.00%
Oper. Margin-2339.60%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-12.97%
ROA-12.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.85M $
CapEx (TTM)—
FCF Margin-1730.83%
FCF Yield-2.36%
Net Debt-125.17M $
Net Debt/EBITDA3.54
Balance Sheet
Debt/Equity0.00
Current Ratio24.26
Quick Ratio23.96
Book Value/Sh0.7010 USD
Cash/Share0.7180 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 18, 2019
Splits
Last Split1:15
Split DateApr 8, 2024
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)10.22 USD
Upside (mean)+386.8%
Target Range5.000 USD – 25.00 USD
$5.000+386.8% to mean$25.00
# Analysts9
Ownership
Shares Out.174.27M
Float138.85M
Insiders1.63%
Institutions101.50%
Short Interest
Short Ratio10.9d
Short % Float19.42%
Short % Out.19.39%
Shares Short33.70M
Short (prev mo.)32.13M
Technical
SMA 501.973 (+6.4%)
SMA 2001.935 (+8.5%)
Beta1.54
S&P 52W Chg18.16%
Avg Vol (30d)2.16M
Avg Vol (10d)1.72M
Technical Indicators
RSI (14)53.4
MACD0.0465
MACD Signal0.0405
MACD Hist.+0.0060
BB Upper2.223 USD
BB Middle2.053 USD
BB Lower1.884 USD
BB Width16.50%
ATR (14)0.1232 USD
Vol Ratio (20d)0.55x